Company / FCF Margin
Myriad Genetics, Inc. FCF Margin History
FY2016-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-22.4%
FY2022
5-year range
-22.4% / 0.1%
FY2018-FY2022
Trend
-24933.3%
vs FY2021
Sector context
#74 of 133
Health Care
What the data says
FCF Margin changed -24933% YoY in FY2022, a notable deviation from the 6-year average annual change of -4185%.
Based on SEC 10-K filings.
-22.4% in FY2022 with a 5-year CAGR of -35.3%.
Declined from 7.9% to -22.4% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- -36.1pp
- 5-Year Change
- -35.3pp
- 10-Year Change
- -
Sector benchmark
#74 of 133 in Health CareTop 56% of 133This company -22.4% Sector average -632.8%
▼
+96.5% above sector average
Key checks
Key Insights
- Myriad Genetics, Inc.'s fcf margin has declined for 4 consecutive years.
- In FY2022, fcf margin decreased 24933.3% year-over-year.
- Currently 610.5pp above the Health Care sector average.
- Peak fcf margin was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score -1.23 (distress zone, below 1.8 threshold)
- Negative profit margin: -15.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | -22.4% | -24933.3% |
| FY2021 | 0.1% | -98.9% |
| FY2020 | 7.9% | -42.4% |
| FY2019 | 13.7% | -4.9% |
| FY2018 | 14.4% | +11.3% |
| FY2017 | 13.0% | -39.3% |
| FY2016 | 21.4% | +32.7% |
As of FY2022 · SEC 10-K · Updated Jun 30, 2026